Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
December 20, 2022 - 6 minutes
European Commission
iOnctura raises €17.5M for pancreatic cancer therapy
iOnctura BV, a clinical-stage biotech developing novel cancer therapies, has been granted €17.5 million ($18.6…
December 20, 2022 - 2 minutes
To avoid stagnation, the EU must refine its ATMP regulation
Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs)…
December 15, 2022 - 8 minutes
European Commission approves Dupixent as first and only targeted prurigo nodularis medicine
The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European…
December 15, 2022 - 5 minutes
BC Platforms partners on AI-driven EU cancer data project
BC Platforms (BCP), a provider of healthcare data management and analytics, has been chosen as…
November 24, 2022 - 2 minutes
Genomic Data Infrastructure Ireland project to support discovery of genetic causes of disease
RCSI University of Medicine and Health Sciences and FutureNeuro are co-leading, with University College Dublin,…
November 21, 2022 - 3 minutes
Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC
Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…
November 18, 2022 - 4 minutes
New EU project looks to unlock the potential of genomics
The European Genomic Data Infrastructure (GDI) project kicked off today in Brussels, Belgium. The new…
November 17, 2022 - 3 minutes
Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial…
November 4, 2022 - 2 minutes
Authorization given to BeiGene’s chemo-free treatment option for lymphoma
Marketing authorization has been granted to a drug to treat relapsed/refractory (R/R) marginal zone lymphoma…
November 2, 2022 - 3 minutes
Oncopeptides starts European commercialization of myeloma drug in Germany
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in…
October 3, 2022 - 2 minutes
Project to tackle biodiversity crisis using the power of DNA data and genomics launched
A project to tackle the biodiversity crisis using DNA data, genomic science that will fundamentally…
September 28, 2022 - 4 minutes
